Clinical Trials
8 trialsNCT01555281 2022-07-07
Nelfinavir and Lenalidomide/Dexamethasone in Progressive Multiple Myeloma
Swiss Cancer Institute
Phase 1/2 Terminated
NCT03050060 2022-06-22
Image Guided Hypofractionated Radiation Therapy, Nelfinavir Mesylate, Pembrolizumab, Nivolumab and Atezolizumab in Treating Patients With Advanced Melanoma, Lung, or Kidney Cancer
University of Washington
Phase 2 Terminated
NCT01108666 2021-07-07
Proton Beam Radiation With Concurrent Chemotherapy and Nelfinavir for Inoperable Stage III Non Small Cell Lung Cancer (NSCLC)
Abramson Cancer Center at Penn Medicine
Phase 2 Terminated
NCT00915694 2019-04-23
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Abramson Cancer Center at Penn Medicine
Phase 1 Terminated
NCT01086332 2018-11-13
Evaluation of Nelfinavir and Chemoradiation for Pancreatic Cancer
University of Iowa
Phase 1 Terminated
NCT00791336 2017-07-28
Study to Evaluate Using Nelfinavir With Chemoradiation for Non-small Cell Lung Cancer
University of Iowa
Phase 2 Terminated
NCT02080416 2016-06-10
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT00233948 2015-04-01
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
City of Hope Medical Center
Phase 1/2 Terminated